Karin Hason-Novoselsky
CTO & Co-Founder
For pharma patient-support programs · specialty & biologic clinics · specialty pharmacies
Patiently keeps patients on therapy.
A clinician-reviewed companion that fuses each patient's live medical record, the program plan, and their own uploads and check-ins - plus a manager slate that shows the program who is on track, who is overdue, and who needs a call. From enrollment through every refill.
Patients fall off therapy between enrollment and the first refill.
1 in 2
new specialty prescriptions never reaches the patient
17%
are abandoned by the patient even after a payor approves them
29%
of patients are still on their newly launched therapy a year later
IQVIA pharmacy-claims analysis of novel specialty medicines launched 2022-2023 (only 44% reach the patient; 17% abandoned after approval; 29% persistent at one year), presented at NASP 2025, reported by Specialty Pharmacy Continuum, Oct 2025. Industry research, not Patiently outcomes.
Map the program once. Patiently runs it per patient.
01
The program defines the therapy journey
Enrollment steps, the therapy plan, check-in questions, side-effect rules, and reminder cadence. Mapped once, per program.
02
Patiently turns it into a patient companion
Each patient gets a single-use magic link - no app to install - that fuses their synced record, the program plan, and their own uploads and check-ins.
03
The program sees the slate
Who is on track, who is overdue, who flagged a severe symptom. One screen, with the single next best action for each patient.
Module 01
Enrollment & time-to-therapy
Enrollment mints the patient an account and a single-use magic link in one step. From there a time-to-first-dose clock and an access funnel show exactly where each patient is held up - benefits investigation, prior authorization, first fill - so the program can clear the blocker instead of guessing.
Module 02
One fused view: program, record, and the patient
The view the reimbursement-first hubs don't have: the program plan, the patient's live synced medical record (Epic / MyChart), and their own uploads and check-ins, reconciled side by side on one readout. Reminders keep refills on schedule, and one tap reports a side effect or a barrier - cost, access, or doubt - straight to the program team.
Module 03
Clinical truth, not claims
Every patient's program therapy is checked against their own connected medical record - not a claim, not a self-report. The slate shows who the record confirms is on therapy, who has no matching fill, and who isn't connected yet, so drop-off risk and the next best action are grounded in the clinical truth. Clinician-reviewed; every AI line carries a pending-review badge.
Module 04
The patient's voice, routed to the team
A two-tap check-in the patient does from their phone - how they're feeling, any side effects, and what's getting in the way: cost, access, a side effect, or just doubt. It goes straight to the program team, so a wobble is caught as a message to answer, not a refill that quietly never happens.
Not a claims console. A clinical companion around the therapy.
Pharma patient-support programs
Specialty & biologic clinics
Specialty pharmacies
Treatment-journey programs
Program signals: time-to-therapy · adherence · side-effect escalations caught · check-in completion - measured per pilot, illustrative until validated.
Built by clinicians and engineers, together.
Erez Hybloom
CEO & Co-Founder
Prof. Shaye Kivity
Chief Medical Officer
Dr. Shalom Mendel
AI & Data Integration
Dr. Nadav Sheffer
Regulatory Advisor
Dr. Ansgar Niehoff
Strategic Technology & Investment
Recognized by the people who run care
2nd place
Clalit HMO Challenge
Cross-HMO innovation challenge (Clalit Innovation, Leumit, Meuhedet), hosted at NVIDIA via HealthSci Consulting and HealthIL.
3rd place
IT Excellence Day
Final projects category, awarded by the Israel Chamber of Information Technology.
Collaboration
Afeka × Meir Medical Center
An academic collaboration with Afeka Academic College of Engineering and Meir Medical Center.
The program console and the patient companion. Best shown live.
Twenty minutes covers scope, price, and the time-to-therapy, adherence, and escalation baseline to measure against. First wedge: one specialty therapy, 20-50 patients, a 30-60 day pilot.
Patiently is a clinician-reviewed patient companion and continuity tool, currently in pilot. It is not a substitute for medical advice and has not been cleared by FDA or any regulatory body. Outcome numbers shown in pilot proposals are targets, not proven results.